Biodesix, Inc. (BDSX) vs Compugen Ltd. (CGEN)

A side-by-side comparison of Biodesix, Inc. and Compugen Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BDSX vs CGEN

growth of $100 · dividends reinvested · last 6y
BDSX -88.7% (-30.4%/yr)CGEN -83.7% (-26.1%/yr)CGEN compounded faster over this window
050100150200250Start $100202120222023202420252026$11$16
BDSX CGEN

BDSX vs CGEN: by the numbers

  • •BDSX is the larger company ($234M vs $215M market cap).
  • •CGEN is profitable (47.55% net margin) while BDSX runs a net loss (-26.97%).
  • •CGEN grew revenue faster over the past five years (105.91% vs 5.99% CAGR).

Metrics side by side

Valuation

MetricBDSXCGEN
P/E ratioN/A6.05
P/S ratio2.282.90
P/B ratio25.622.42

Profitability

MetricBDSXCGEN
Gross margin82.50%86.89%
Operating margin-31.37%40.94%
Net margin-26.97%47.55%
ROE-303.61%39.66%
ROIC-25.73%26.14%

Growth (annualized)

MetricBDSXCGEN
Revenue CAGR (5Y)5.99%105.91%
Total return CAGR (5Y)-28.49%-18.39%

Frequently asked

Which has grown faster, BDSX or CGEN?
Over the past five years, CGEN grew revenue faster — BDSX at a 5.99% CAGR versus CGEN at 105.91%.
Is BDSX or CGEN more profitable?
CGEN runs the higher net margin — BDSX at -26.97% versus CGEN at 47.55%.
How have BDSX and CGEN total returns compared?
Over the past 5 years, BDSX delivered -28.49% and CGEN delivered -18.39% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.